New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2016-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2016.04.003PMID 27072910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling*

  2015cited by this paper
• New trisubstituted 1,2,4-triazoles as ghrelin receptor antagonists.

  2015cited by this paper
• Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.

  2014cited by this paper
• Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency

  2013cited by this paper
• Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a.

  2011cited by this paper
• Multi-gram scale mercury-free synthesis of optically pure 3,4,5-trisubstituted 1,2,4-triazoles using silver benzoate

  2010cited by this paper
• Requirement of central ghrelin signaling for alcohol reward

  2009cited by this paper
• New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.

  2008cited by this paper
• Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.

  2007cited by this paper
• Physiological, pathological and potential therapeutic roles of ghrelin.

  2007cited by this paper
• Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism*

  2007cited by this paper
• PRECLINICAL STUDY: Ghrelin stimulates locomotor activity and accumbal dopamine‐overflow via central cholinergic systems in mice: implications for its involvement in brain reward

  2006cited by this paper
• Ghrelin Receptor Inverse Agonists: Identification of an Active Peptide Core and Its Interaction Epitopes on the Receptor

  2006cited by this paper
• International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function

  2005cited by this paper
• Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation.

  2004cited by this paper
• Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.

  2004cited by this paper
• Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects.

  2004cited by this paper
• Solution and solid-supported synthesis of 3,4,5-trisubstituted 1,2,4-triazole-based peptidomimetics.

  2003cited by this paper
• New active series of growth hormone secretagogues.

  2003cited by this paper
• High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.

  2003cited by this paper
• EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

  2002cited by this paper
• Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.

  2000cited by this paper
• Ghrelin strongly stimulates growth hormone release in humans.

  2000cited by this paper
• Ghrelin stimulates gastric acid secretion and motility in rats.

  2000cited by this paper
• Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat

  1999cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues.

  1997cited by this paper
• A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release

  1996cited by this paper

• Cycloaddition of Nitrile Imine to (R)-(–)-Carvone

  2025cites this paper
• Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor

  2022cites this paper
• Design and Characterization of a Triazole-Based Growth Hormone Secretagogue Receptor Modulator Inhibiting the Glucoregulatory and Feeding Actions of Ghrelin.

  2022cites this paper
• Development of non-peptidic inverse agonists of the ghrelin receptor (GHSR) based on the 1,2,4-triazole scaffold.

  2020cites this paper
• Structure and dynamics of G protein-coupled receptor–bound ghrelin reveal the critical role of the octanoyl chain

  2019cites this paper
• Synthesis of [1,2,4]Triazolo[4,3- a]piperazin-6-ones: An Approach to the Triazole-Fused Ketopiperazine Scaffold.

  2018cites this paper
• Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases.

  2018cites this paper